This is exactly my thinking for proposing the idea. Mylan intimately knows the difficulty in getting a Gx copaxone approved and also intimately knows MNTA through all the litigation (and I think CW mentioned he knows Heather Bresch pretty well cause of all those generic organizations their own together). Perhaps just coincidence, but 6 months ago is about when MYL stopped mentioned Gx all together (and seems like a fair amount of time ago that these talks would have started).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.